SPP1 and plasma cell myeloma: The pre-transplant osteopontin levels in allotransplant recipients were high (median: 126 ng/mL; range: 80–438 ng/mL) and were significantly higher than the levels in healthy individuals (p < 0.001; see Table 1), and even higher than for the myeloma patients (p = 0.02).